Lower serum CA125 level, negative vascular invasion, and wild BRAF were strongly associated with better 2-year disease-free survival in patients with stage III colorectal cancer who received adjuvant chemotherapy.
Chang, Shu-Jian
Lower serum CA125 level, negative vascular invasion, and wild BRAF were strongly associated with better 2-year disease-free survival in patients with stage III colorectal cancer who received adjuvant chemotherapy. [electronic resource] - Cancer biomarkers : section A of Disease markers 2018 - 161-168 p. digital
Publication Type: Journal Article
1875-8592
10.3233/CBM-181179 doi
Aged
CA-125 Antigen--blood
Chemotherapy, Adjuvant
Colorectal Neoplasms--blood
Disease-Free Survival
Female
Humans
Male
Neoplasm Staging
Proto-Oncogene Proteins B-raf--genetics
Survival Rate
Time Factors
Lower serum CA125 level, negative vascular invasion, and wild BRAF were strongly associated with better 2-year disease-free survival in patients with stage III colorectal cancer who received adjuvant chemotherapy. [electronic resource] - Cancer biomarkers : section A of Disease markers 2018 - 161-168 p. digital
Publication Type: Journal Article
1875-8592
10.3233/CBM-181179 doi
Aged
CA-125 Antigen--blood
Chemotherapy, Adjuvant
Colorectal Neoplasms--blood
Disease-Free Survival
Female
Humans
Male
Neoplasm Staging
Proto-Oncogene Proteins B-raf--genetics
Survival Rate
Time Factors